May 12, 2021By: Rounak Jain
The Sunil Mittal-led telco added 3.7 million subscribers in February, close on the heels of market leader Reliance Jio.
It has received royalty-free licence from US drugmaker Eli Lilly & Co to produce Baricitinib drug in India to fight COVID-19.
Like Sun Pharma, Dr. Reddy’s has also received a royalty-free licence from Eli Lilly & Co to produce Baricitinib drug in India.
Its telecom arm Jio has bounced back to add over 4.2 million subscribers in February.
Apollo Tyres, Asian Paints, Tata Power, Jindal Steel & Power, Happiest Minds Technologies, Borosil Renewables, Birla Corporation, HG Infra Engineering, JSW Ispat Special Products, Pidilite Industries, Saregama India, UPL.
It has announced a strategic partnership with Britvic to provide end-to-end IT services, helping Britvic in digital transformation.
It expects its June 2021 quarter volumes to fall by up to 20 percent compared to the previous quarter. This will have an impact on its revenue and profitability, it said.
It reported a 90 percent jump in its net profit in the March 2021 quarter, surging to ₹334 crore. Revenue increased 32 percent to ₹3,484 crore, year-on-year.
Its March 2021 quarter net profit rose by 59 percent to ₹366 crore while revenue increased by 27 percent to ₹2,731 crore, year-on-year.
It reported a nearly 8-fold jump in its net profit in the March 2021 quarter to ₹303 crore while revenue increased by 17 percent to ₹441 crore, year-on-year.